Venus Concept Inc. (VERO)
NASDAQ: VERO · Real-Time Price · USD
2.690
+0.320 (13.50%)
At close: Oct 8, 2025, 4:00 PM EDT
2.490
-0.200 (-7.43%)
After-hours: Oct 8, 2025, 7:15 PM EDT
Venus Concept Market Cap
Venus Concept has a market cap or net worth of $5.00 million as of October 8, 2025. Its market cap has decreased by -16.65% in one year.
Market Cap
5.00M
Enterprise Value
37.44M
1-Year Change
-16.65%
Ranking
Category
Stock Price
$2.69
Market Cap Chart
Since October 12, 2017, Venus Concept's market cap has decreased from $278.20M to $5.00M, a decrease of -98.20%. That is a compound annual growth rate of -39.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 4.40M | 62.96% |
| Dec 31, 2024 | 2.70M | -58.46% |
| Dec 29, 2023 | 6.50M | -69.91% |
| Dec 30, 2022 | 21.60M | -76.55% |
| Dec 31, 2021 | 92.10M | 29.35% |
| Dec 31, 2020 | 71.20M | -48.92% |
| Dec 31, 2019 | 139.40M | 687.57% |
| Dec 31, 2018 | 17.70M | -86.70% |
| Dec 29, 2017 | 133.10M | -52.16% |
| Oct 12, 2017 | 278.20M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 757.36B |
| Johnson & Johnson | 454.91B |
| AbbVie | 411.31B |
| UnitedHealth Group | 329.36B |
| AstraZeneca | 266.44B |
| Novo Nordisk | 261.01B |
| Novartis AG | 255.35B |
| Abbott Laboratories | 231.52B |